Quest Diagnostics (DGX) Total Non-Current Liabilities (2009 - 2026)

Quest Diagnostics has disclosed Total Non-Current Liabilities across 18 years of filings, most recently posting $8.3 billion for Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $8.3 billion, up 4.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.3 billion (up 4.64% YoY), and the FY2025 annual result was $8.1 billion, down 3.62% from the prior year.
• Total Non-Current Liabilities came in at $8.3 billion for Q1 2026 at Quest Diagnostics, up from $8.1 billion in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $8.4 billion in Q4 2024 to a low of $5.9 billion in Q1 2023.
• The 5-year median for Total Non-Current Liabilities is $7.0 billion (2023), against an average of $7.1 billion.
• Across the five-year window, Total Non-Current Liabilities slipped 6.17% in 2023 and surged 36.09% in 2024, its largest moves.
• Quest Diagnostics' Total Non-Current Liabilities stood at $6.1 billion in 2022, then rose by 11.63% to $6.8 billion in 2023, then gained by 23.49% to $8.4 billion in 2024, then retreated by 3.62% to $8.1 billion in 2025, then rose by 2.31% to $8.3 billion in 2026.
• The last three Total Non-Current Liabilities figures came in at $8.3 billion (Q1 2026), $8.1 billion (Q4 2025), and $8.0 billion (Q3 2025), per Business Quant data.